• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INVATEC TECHNOLOGY CENTER GMBH IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INVATEC TECHNOLOGY CENTER GMBH IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vasoconstriction (2126)
Event Date 01/01/2012
Event Type  Injury  
Manufacturer Narrative
Event date: approximate event date.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
During the use with inpact pacific, inpact admiral and inpact amphiprion drug eluting balloons, it was reported that a physician indicated he has observed slow / low flow in spite of using vasorelaxants (e.G., nitro, gb23a/amixibab).The situation appeared to be temporary and resolved itself within a reasonable time without re-intervention.The physician reported that it could be related to clearance through the microvasculature and that it was not the vessel itself that spasms or narrows, but an increased impedance on downstream clearance caused either by multiple lateral plaque shifts (exacerbated by the use of multiple short balloons) or by matrix particles.No patient safety concerns were expressed.This was reported as an observation by the physician.The physician reported the observation rate was very low at ~5%.From the perspective of safety, the physician indicated that the phenomenon rapidly and easily resolved in 5m with the use of abciximab, so he felt he had an adequate resolution when this infrequent condition was observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
INVATEC TECHNOLOGY CENTER GMBH
hungerbuelstrasse 12
frauenfeld 8500
CH  8500
Manufacturer (Section G)
INVATEC TECHNOLOGY CENTER GMBH
hungerbuelstrasse 12
frauenfeld 8500
CH   8500
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key5650616
MDR Text Key45038885
Report Number3004066202-2016-00155
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P140010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/05/2016
Initial Date FDA Received05/12/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/14/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-